echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Seven trends in global health and life sciences in 2015

    Seven trends in global health and life sciences in 2015

    • Last Update: 2014-11-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: at present, on November 26, 2014, forbes.cn, in the highly competitive field of global health science, especially in the field of life science, significant changes are taking place As 2015 approaches, health leaders must understand the trends and changes that are taking place around them, not just in the United States, but in markets, cities and services in other countries Due to unprecedented connectivity, changing demographic characteristics, significant growth in patent applications in emerging markets, and changes in global pharmaceutical demand, hospital leadership, policy makers, manufacturers, inventors, and physicians in the United States must know where to go in 2015 and beyond According to JLL's 2014 global life sciences cluster report, here are seven trends you need to know in 2015 1 Although North America and Europe still have the largest number of Patent Cooperation Treaty (PCT) applications (41% and 31% respectively) every year, significant changes are taking place PCT application volume is an international standard to measure innovation output PCT applications are growing in Asia, Latin America and the Caribbean, and the gap is expected to continue to narrow To some extent, this trend can be attributed to the transfer of a wide range of physiological maturity of chronic diseases from developed countries to developing countries As a result, many advanced cities and companies are turning to specific and personalized biological agents and health care products For example, biosimilars are increasingly popular in the United States and Europe, and diabetes has become a major concern in the Middle East and North Africa Innovation growth PCT applications for life sciences grew by 3.7% between 2011 and 2012 The leading growth countries include China, Russia, Switzerland, Japan, Germany, Mexico, the Netherlands and Brazil 2 Between 1993 and 2010, the proportion of science and engineering employees aged over 50 increased from 20% to 33% Moreover, it is estimated that 2 million engineering and life science posts will be vacated by 2020, mainly due to the retirement of old employees In 2014, manpower group conducted a global annual survey of 38000 employees in 42 countries 35% of the employees said they had difficulty in recruitment Among them, 54% said that the difficulty in recruitment directly affected their ability to meet customer needs For example, in China, the one-child policy has made it difficult for the current medical team to cope with the aging population, which is exactly what Intel wants to solve Because the U.S labor force is aging relative to the young labor force in developing countries, the authors of Harvard Business Review have suggested that the U.S should delay the retirement age Flexible working hours, new technology, new training programs and different skill requirements will lead to major changes in the American business community, especially in the fields of pharmaceuticals and medical devices in the health ecosystem Although stem (Science, technology, engineering and Mathematics) education programs for women have become increasingly popular in the United States, there are still too few women in this field (only 23% of engineering practitioners in 2008) Female workers may help meet employment needs in health and technology 3 As expected, Japan and the United States have the highest statutory corporate tax burden (39.5% and 39.1%, respectively) Some say it hinders innovation, but others say it just prevents companies from investing in the United States Medtronic, for example, recently planned to acquire Covidien, presumably to keep money in Ireland, where tax rates are low However, the United States and Japan also have the most perfect regulatory system and high political transparency in the world, which makes the production and sales of many enterprises easier "Federal policies in the United States, such as corporate tax structures and regulatory frameworks, have a direct impact on the establishment and development of life sciences companies," said Roger Humphrey, executive director of Jones Lang LaSalle's Life Sciences Division Tax and regulatory Japan and the United States have the highest statutory corporate tax burden, 39.5% and 39.1% respectively But the two countries also have the most complete regulatory system and high political transparency The statutory corporate tax rates are Ireland, Switzerland, the United Kingdom, South Korea, the Netherlands, Israel, Canada, Sweden, Australia, Spain, Mexico, Germany, France, the United States and Japan 4 Educate the U.S still has the highest proportion of highly educated (Bachelor's degree or above) working people (25-64 years old) However, this no longer applies to young people in the United States For example, in terms of the proportion of workers aged 25-34 with bachelor's degree or above, South Korea (39%), the Netherlands (38%), the UK (38%) and Australia (34%) are all higher than the United States (33%) "The United States is rapidly losing its leading edge due to the rapid spread of higher education in industrialized countries and emerging economies," according to the 2011 OECD report 5 At present, 10 countries account for 80% of global R & D investment As enterprises are the largest source of R & D funds, investor confidence and the overall economic situation have a significant impact on R & D investment Burrill's report claims that confidence in biotechnology seems to have recovered In 2013, the U.S life science IPO activity was a good year, with 52 IPOs, raising a total of $7 billion, far higher than the 16 and $1 billion in 2012 However, at the national level, by the beginning of 2020, China's R & D investment may surpass that of the United States 6 The threshold of entrepreneurship has been lowered in most countries, especially in the more developed international cities This is in sharp contrast to the emerging life science cluster "We find that the UK and the Netherlands have always been the countries with the lowest barriers to entrepreneurship, while China and India currently have the highest," henfrey said He claims that this is because the cooperation and risk sharing model of these emerging markets is not perfect 7 Differences in labor productivity: between 2003 and 2012, the labor productivity of developing countries increased by 5%, while that of developed countries increased by 1% Labor productivity refers to how many products and services can be produced per hour of labor A continuing trend (tracked from 2007) is that annual increases in labour productivity are benefiting developing countries With the growth of wealth, the degree of specialization and cost-effectiveness are also rising.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.